Skip to content

Clinical trials

Completed Phase 2 Atrial Fibrillation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 2 Status: Completed Clear all

80 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20057
20067
20078
20088
20094
20105
20118
20128
20133
20143
20172
20182
20194
20203
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed80

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Meshalkin Research Institute of Pathology of Circulation8
Bayer5
GlaxoSmithKline4
AstraZeneca3
ARYx Therapeutics2
Advanz Pharma2
Astellas Pharma Inc2
AtriCure, Inc.2
Boehringer Ingelheim2
Daiichi Sankyo Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation80
Stroke6
Arrhythmias, Cardiac5
Atrial Flutter4
Thromboembolism4
Venous Thromboembolism4
Cardiovascular Diseases3
Cerebral Hemorrhage2
Heart Valve Diseases2
Hypertension2

Trials

Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.